Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
11 2023
Historique:
revised: 07 11 2022
received: 24 03 2022
accepted: 14 11 2022
medline: 2 11 2023
pubmed: 10 1 2023
entrez: 9 1 2023
Statut: ppublish

Résumé

This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype analysis by flow cytometry, generation, fluorescence microscopy, and functional characterization of mouse and human dendritic cells (DC) from lymphoid organs and various non-lymphoid tissues. Here, we provide detailed procedures for a variety of multiparameter fluorescence microscopy imaging methods to explore the spatial organization of DC in tissues and to dissect how DC migrate, communicate, and mediate their multiple functional roles in immunity in a variety of tissue settings. The protocols presented here entail approaches to study DC dynamics and T cell cross-talk by intravital microscopy, large-scale visualization, identification, and quantitative analysis of DC subsets and their functions by multiparameter fluorescence microscopy of fixed tissue sections, and an approach to study DC interactions with tissue cells in a 3D cell culture model. While all protocols were written by experienced scientists who routinely use them in their work, this article was also peer-reviewed by leading experts and approved by all co-authors, making it an essential resource for basic and clinical DC immunologists.

Identifiants

pubmed: 36623939
doi: 10.1002/eji.202249923
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2249923

Informations de copyright

© 2023 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Références

Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, E. et al., Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 2014. 14: 571-578.
Nutt, S. L. and Chopin, M., Transcriptional Networks Driving Dendritic Cell Differentiation and Function. Immunity. 2020. 52: 942-956.
Cabeza-Cabrerizo, M., Cardoso, A., Minutti, C. M., Pereira da Costa, M. and Reis e Sousa, C., Dendritic Cells Revisited. Annu. Rev. Immunol. 2021. 39:131-166.
Dalod, M. and S. Scheu. Dendritic cell functions in vivo: A user's guide to current and next- generation mutant mouse models. Eur. J. Immunol. 2022. 52:1712-1749.
Kastenmüller, W., Gerner, M. Y. and Germain, R. N., The in situ dynamics of dendritic cell interactions. Eur J Immunol 2010. 40: 2103-2106.
Uderhardt, S., Martins, A. J., Tsang, J. S., Lämmermann, T. and Germain, R. N., Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage. Cell. 2019. 177: 541-555. e17.
Mempel, T. R., Henrickson, S. E. and Von Andrian, U. H., T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 2004. 427: 154-159.
Seder, R. A., Paul, W. E., Davis, M. M. and Fazekas de St Groth, B., The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 1992, 176: 1091-1098.
Barnden, M. J., Allison, J., Heath, W. R. and Carbone, F. R., Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 1998. 76: 34-40.
Pircher, H., Moskophidis, D., Rohrer, U., Bürki, K., Hengartner, H. and Zinkernagel, R. M., Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 1990. 346: 629-633.
Victora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L. and Nussenzweig, M. C., Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell. 2010. 143: 592-605.
Medaglia, C., Giladi, A., Stoler-Barak, L., De Giovanni, M., Salame, T. M., Biram, A., David, E. et al., Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science. 2017. 358: 1622-1626.
van Panhuys, N., Klauschen, F. and Germain, R. N., T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo. Immunity. 2014. 41: 63-74.
Muccioli, M., Pate, M., Omosebi, O. and Benencia, F., Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies. J. Vis. Exp. 2011. 52: 2785.
Lindquist, R. L., Shakhar, G., Dudziak, D., Wardemann, H., Eisenreich, T., Dustin, M. L. and Nussenzweig, M. C., Visualizing dendritic cell networks in vivo. Nat. Immunol. 2004. 5: 1243-1250.
Satpathy, A. T., Wumesh, K. C., Albring, J. C., Edelson, B. T., Kretzer, N. M., Bhattacharya, D., Murphy, T. L. et al., Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 2012. 209: 1135-1152.
Lechmann, M., Shuman, N., Wakeham, A. and Mak, T. W., The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008. 105: 11887-11892.
Stranges, P. B., Watson, J., Cooper, C. J., Choisy-Rossi, C.-M., Stonebraker, A. C., Beighton, R. A., Hartig, H. et al., Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity. 2007. 26: 629-641.
Loschko, J., Schreiber, H. A., Rieke, G. J., Esterházy, D., Meredith, M. M., Pedicord, V. A., Yao, K.-H. et al., Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation. J. Exp. Med. 2016. 213: 517-534.
Schraml, B. U., van Blijswijk, J., Zelenay, S., Whitney, P. G., Filby, A., Acton, S. E., Rogers, N. C. et al., Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell. 2013. 154: 843-858.
Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T. et al., cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity. Nature. 2020. 584: 624-629.
Mattiuz, R., Wohn, C., Ghilas, S., Ambrosini, M., Alexandre, Y. O., Sanchez, C., Fries, A. et al., Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity in vivo. Front. Immunol. 2018. 9: 2805.
Zahner, S. P., Kel, J. M., Martina, C. A. E., Brouwers-Haspels, I., van Roon, M. A. and Clausen, B. E., Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity. J. Immunol. 2011. 187: 5069-5076.
Murooka, T. T. and Mempel, T. R., Multiphoton Intravital Microscopy to Study Lymphocyte Motility in Lymph Nodes. Integrin and Cell Adhesion Molecules: Methods and Protocols. 2012. 757: 247-257.
Crainiciuc, G., Palomino-Segura, M., Molina-Moreno, M., Sicilia, J., Aragones, D. G., Li, J. L. Y., Madurga, R. et al., Behavioural immune landscapes of inflammation. Nature. 2022. 601: 415-421.
Faust, N., Varas, F., Kelly, L. M., Heck, S. and Graf, T., Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Am. J. Blood Res. 2000. 96: 719-726.
Bousso, P., T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 2008. 8: 675-684.
Textor, J., Peixoto, A., Henrickson, S. E., Sinn, M., von Andrian, U. H. and Westermann, J., Defining the quantitative limits of intravital two-photon lymphocyte tracking. Proc. Natl. Acad. Sci. U. S. A. 2011. 108: 12401-12406.
Miller, M. J., Safrina, O., Parker, I. and Cahalan, M. D., Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 2004. 200: 847-856.
Mempel, T. R., Pittet, M. J., Khazaie, K., Weninger, W., Weissleder, R., von Boehmer, H. and von Andrian, U. H., Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity. 2006. 25: 129-141.
Liu, Z., Gu, Y., Chakarov, S., Bleriot, C., Kwok, I., Chen, X., Shin, A. et al., Fate mapping via Ms4a3-expression history traces monocyte-derived cells. Cell 2019. 178: 1509-1525. e1519.
Schlitzer, A., Sivakamasundari, V., Chen, J., Sumatoh, H. R., Schreuder, J., Lum, J., Malleret, B. et al., Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progen- itor stage in the bone marrow. Nat. Immunol. 2015. 16: 718-728.
Becher, B., Schlitzer, A., Chen, J., Mair, F., Sumatoh, H. R., Teng, K. W., Low, D., Ruedl, C. et al., High-dimensional analysis of the murine myeloid cell system. Nat. Immunol. 2014. 15: 1181-1189.
Schlitzer, A., McGovern, N., Teo, P., Zelante, T., Atarashi, K., Low, D., Ho, A. W. et al., IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity. 2013. 38: 970-83.
Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., Black, S. and Nolan, G. P., Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging. Cell. 2018. 174: 968-981. e15.
Schürch, C. M., Bhate, S. S., Barlow, G. L., Phillips, D. J., Noti, L., Zlobec, I., Chu, P. et al., Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front. Cell. 2020. 182: 1341-1359. e19.
Stoltzfus, C. R., Filipek, J., Gern, B. H., Olin, B. E., Leal, J. M., Wu, Y., Lyons-Cohen, M. R. et al., CytoMAP: A Spatial Analysis Toolbox Reveals Features of Myeloid Cell Organization in Lymphoid Tissues. Cell Rep. 2020. 31: 107523.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S. et al., Fiji: an open-source platform for biological-image analysis. Nat. Methods 2012. 9: 676-682.
Du, Z., Lin, J. R., Rashid, R., Maliga, Z., Wang, S., Aster, J. C., Izar, B. et al., Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nat. Protoc. 2019. 14: 2900-2930.
Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J. et al., Circos: An information aesthetic for comparative genomics. Genome. Res. 2009. 19: 1639-1645.
Fridman, W. H., Zitvogel, L., Sautès-Fridman, C., Kroemer, G., The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin Oncol. 2017. 14: 717-734.
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., et al,. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 2018. 24: 541-550.
Bruni, D., Angell, H. K., Galon, J., The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 2020. 20: 662-680.
Massi, D., Rulli, E., Cossa, M., Valeri, B., Rodolfo, M., Merelli, B., De Logu, F. et al., The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. J. Immunother. Cancer. 2019. 7: 308.
Parra, E. R., Zhai, J., Tamegnon, A., Zhou, N., Pandurengan, R. K., Barreto, C., Jiang, M. et al., Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues. Sci. Rep. 2021. 11: 4530.
Hofman, P., Badoual, C., Henderson, F., Berland, L., Hamila, M., Long-Mira, E., Lassalle, S. et al., Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time? Cancers. 2019. 11: 283.
Huang, Y. K., Wang, M., Sun, Y., Di Costanzo, N., Mitchell, C., Achuthan, A., Hamilton, J. A. et al., Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry. Nat. Commun. 2019. 10: 3928.
Berry, S., Giraldo, N. A., Green, B. F., Cottrell, T. R., Stein, J. E., Engle, E. L., Xu, H. et al., Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade. Science. 2021. 372: eaba2609.
Edwards, J., Wilmott, J. S., Madore, J., Gide, T. N., Quek, C., Tasker, A., Ferguson, A. et al., CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment. Clin. Cancer Res. 2018. 24: 3036-3045.
Allam, M., Cai, S. and Coskun, A. F., Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics. npj Precis. Onc. 2020. 4: 1-14.
Kießler, M., Plesca, I., Sommer, U., Wehner, R., Wilczkowski, F., Müller, L., Tunger, A. et al., Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J. Immunother. Cancer 2021. 9: e001813.
Böttcher, J. P. and Reis e Sousa, C., The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity. Trends Cancer 2018. 4: 784-792.
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F. and Sancho, D., Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 2020. 20: 7-24.
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A. et al., Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 2014. 26: 638-652.
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C. et al., NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018. 172: 1022-1037. e14.
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E. et al., A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat. Med. 2018. 24: 1178-1191.
Michea, P., Noël, F., Zakine, E., Czerwinska, U., Sirven, P., Abouzid, O., Goudot, C. et al., Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific. Nat. Immunol. 2018. 19: 885-897.
Spranger, S., Dai, D., Horton, B. and Gajewski, T. F., Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. Cancer Cell 2017. 31: 711-723. e4.
Chow, M. T., Ozga, A. J., Servis, R. L., Frederick, D. T., Lo, J. A., Fisher, D. E., Freeman, G. J. et al., Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. Immunity. 2019. 50: 1498-1512.e5.
Hubert, M., Gobbini, E., Couillault, C., Manh, T-P. V., Doffin, A-C., Berthet, J., Rodriguez, C. et al., IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Sci. Immunol. 2020. 5: eaav3942.
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I. et al., Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. Immunity. 2019. 50: 1317-1334. e10.
Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y., Jessell, T. M., Costantini, F., Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001. 1: 4.
Yamazaki, C., Sugiyama, M., Ohta, T., Hemmi, H., Hamada, E., Sasaki, I., Fukuda, Y. et al., Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J. Immunol. 2013. 190: 6071-6082.
Kitano, M., Yamazaki, C., Takumi, A., Ikeno, T., Hemmi, H., Takahashi, N., Shimizu, K. et al., Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. Proc. Natl. Acad. Sci. USA. 2016. 113: 1044-1049.
Schönheit, J., Kuhl, C., Gebhardt, M. L., Klett, F. F., Riemke, P., Scheller, M., Huang, G. et al., PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment. Cell Rep. 2013. 3: 1617-1628.
Reinhardt, R. L., Hong, S., Kang, S-J., Wang, Z-E., Locksley, R. M., Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 2006. 177: 1618-1627.
Groom, J. R., Richmond, J., Murooka, T. T., Sorensen, E. W., Sung, J. H., Bankert, K., von Andrian, U. H. et al., CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity. 2012. 37: 1091-1103.
Nakano, H., Burgents, J. E., Nakano, K., Whitehead, G. S., Cheong, C., Bortner, C. D. and Cook, D. N., Migratory properties of pulmonary dendritic cells are determined by their developmental lineage. Mucosal. Immunol. 2013; 6:678-691.
Gerner, M. Y., Kastenmüller, W., Ifrim, I., Kabat, J. and Germain, R. N., Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity. 2012. 37: 364-376.
Li, W., Germain, R. N., Gerner, M. Y., Multiplex, quantitative cellular analysis in large tissue volumes with clearing-enhanced 3D microscopy (Ce3D). Proc. Natl. Acad. Sci. USA. 2017. 114: E7321-E7330.
Li, W., Germain, R. N. and Gerner, M. Y., High-dimensional cell-level analysis of tissues with Ce3D multiplex volume imaging. Nat. Protoc. 2019. 165: 1-29.
Laoui, D., Keirsse, J., Morias, Y., Van Overmeire, E., Geeraerts, X., Elkrim, Y., Kiss, M. et al., The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nat. Commun. 2016. 7: 13720.
Lavin, Y., Kobayashi, S., Leader, A., Amir, E. D., Elefant, N., Bigenwald, C., Remark, R. et al., Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell. 2017. 169: 750-765. e17.
Posch, W., Vosper, J., Noureen, A., Zaderer, V., Witting, C., Bertacchi, G., Gstir, R. et al., C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia, J. Allergy Clin. Immunol. 2021. 147: 2083-2097. e6.
Posch, W., Lass-Flörl, C. and Wilflingseder, D., SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion. J. Allergy Clin. Immunol. 2021. 148: 909.
Posch, W., Vosper, J., Zaderer, V., Noureen, A., Constant, S., Bellman-Weiler, R., Lass-Flörl, C. et al., ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia. mBio 2021. 12: e00904-21.
Lafon, E., Diem, G., Witting, C., Zaderer, V., Bellmann-Weiler, R. M., Reindl, M., Bauer, A. et al., Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Front. Immunol. 2021. 12: 684014.
Chen, Y. W., Huang, S. X., de Carvalho, A. L. R. T., Ho, S. H., Islam, M. N., Volpi, S., Notarangelo, L. D. et al., A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell. Biol. 2017. 19: 542-549.
Bucchieri, F., Pitruzzella, A., Fucarino, A., Gammazza, A. M., Bavisotto, C. C., Marcianò, V., Cajozzo, M. et al., Functional characterization of a novel 3D model of the epithelial-mesenchymal trophic unit. Exp. Lung. Res. 2017. 43: 82-92.
Tomašek, I., Horwell, C. J., Damby, D. E., Barošová, H., Geers, C., Petri-Fink, A., Rothen-Rutishauser, B. et al., Combined exposure of diesel exhaust particles and respirable Soufrière Hills volcanic ash causes a (pro-)inflammatory response in an in vitro multicellular epithelial tissue barrier model. Part. Fibre Toxicol. 2016. 13: 67.
Osswald, A., Hedrich, V. and Sommergruber, W., 3D-3 Tumor Models in Drug Discovery for Analysis of Immune Cell Infiltration. Methods Mol. Biol. 2019. 1953: 151-162.
Zaderer, V., Hermann, M., Lass-Flörl, C., Posch, W. and Wilflingseder, D., Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model. Mol. Cells 2019. 8: 1292.
Chandorkar, P., Posch, W., Zaderer, V., Blatzer, M., Steger, M., Ammann, C. G., Binder, U. et al., Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections. Sci. Rep. 2017. 7: 11644.
Luvanda, M. K., Posch, W., Noureen, A., Lafon, E., Zaderer, V., Lass-Flörl, C. and Wilflingseder, D., Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model. J. Fungi. 2021. 7: 221.
Schönfeld, M., Knackmuss, U., Chandorkar, P., Hörtnagl, P., Hope, T. J., Moris, A., Bellmann-Weiler, R. et al., Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity. Front. Immunol. 2019. 10: 1123.

Auteurs

Felix Bayerl (F)

Institute of Molecular Immunology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich (TUM), Ismaninger Str. 22, Munich, Germany.

David A Bejarano (DA)

Quantitative Systems Biology, Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.

Giulia Bertacchi (G)

Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Anne-Claire Doffin (AC)

Cancer Research Center Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, 28 rue Laennec, Lyon, France.

Elisa Gobbini (E)

Cancer Research Center Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, 28 rue Laennec, Lyon, France.

Margaux Hubert (M)

Cancer Research Center Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, 28 rue Laennec, Lyon, France.

Lijian Li (L)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
Exploratory Research Unit, Optical Imaging Centre Erlangen (OICE), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Philippa Meiser (P)

Institute of Molecular Immunology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich (TUM), Ismaninger Str. 22, Munich, Germany.

Anna-Marie Pedde (AM)

Institute of Molecular Immunology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich (TUM), Ismaninger Str. 22, Munich, Germany.

Wilfried Posch (W)

Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Luise Rupp (L)

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.

Andreas Schlitzer (A)

Quantitative Systems Biology, Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.

Marc Schmitz (M)

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Barbara U Schraml (BU)

Walter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, Planegg-Martinsried, Germany.
Biomedical Center, Institute for Cardiovascular Physiology and Pathophysiology, Faculty of Medicine, LMU Munich, Planegg-Martinsried, Germany.

Stefan Uderhardt (S)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
Exploratory Research Unit, Optical Imaging Centre Erlangen (OICE), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Jenny Valladeau-Guilemond (J)

Cancer Research Center Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, 28 rue Laennec, Lyon, France.

Doris Wilflingseder (D)

Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Viktoria Zaderer (V)

Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Jan P Böttcher (JP)

Institute of Molecular Immunology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich (TUM), Ismaninger Str. 22, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH